Figure 1.
Photographs of the patient's face at the start of highly active antiretroviral therapy (HAART) in 1988 (A), at the start of pioglitazone therapy and change of HAART regimen in 2012 (B), and after 18 months of pioglitazone therapy (C).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.